Extraorbital idiopathic pseudotumors of the skull base are very uncommon. We report the case of a 50-year-old woman who presented with left ophthalmoplegia and vision loss. Imaging studies revealed an enhancing lesion involving the left petrous apex and cavernous sinus. A transnasal endoscopic approach was used to obtain a biopsy of the left petrous apex. Pathology identified the lesion as an idiopathic pseudotumor. The patient was treated with high-dose steroids and steroid-sparing immunomodulators, and she experienced a significant improvement. To the best of our knowledge, this is the first reported case of a transnasal endoscopic approach to a biopsy of a pseudotumor involving the petrous apex. We discuss the features of this case, and we review the literature on this condition.
Introduction
The term pseudotumor refers to an inflammatory lesion that usually presents in the orbit. This nonspecific collection of inflammation has been reported to represent 5 to 16% of orbital masses in adults. 1 In rare instances, idiopathic pseudotumors have been found outside the orbit. Only about 20 cases of extraorbital pseudotumor have been described; these have been reported in areas such as the skull base, parapharyngeal space, pterygopalatine fossa, nasopharynx, nasal cavities, and paranasal sinuses. 2 The diagnosis and treatment of a pseudotumor of the skull base can be challenging. The diagnosis of this condition often requires a tissue biopsy. We review a case of an extraorbital pseudotumor of the petrous apex and cavernous sinus, and we describe our biopsy of the petrous apex via a transnasal endoscopic approach. Fortunately, recent advances in endoscopic techniques allow surgeons to obtain tissue samples with less morbidity than is typical with open surgical techniques.
Case report
A 50-year-old woman presented to our ENT department with worsening left-sided headaches and double vision. Physical examination revealed a significant vision loss in the left eye and a limitation of the left lateral gaze. No other focal neurologic deficits were found.
Contrast-enhanced computed tomography (CT) identified a lytic lesion of the left petrous apex. Follow-up magnetic resonance imaging (MRI) further delineated the enhancing lesion, which measured approximately 2 × 2 cm and was seen not only in the left petrous apex, but also in the cavernous sinus; there was no orbital involvement (figure 1). Laboratory studies found only nonspecific inflammatory markers, and an autoimmune workup was negative. Based on the imaging results, a biopsy was planned for diagnostic purposes.
Consideration was given to various surgical techniques that could be used to access the petrous apex. Ultimately, we chose to obtain the specimen via a transnasal endoscopic approach. After a wide sphenoidotomy was performed (figure 2), the petrous apex was accessed by exposing the area just posterior to the vertical segment of the left internal carotid artery ( figure 3 ). The bone in this area was removed by drilling, and dissection proceeded posteriorly and laterally to the internal carotid artery. As the petrous apex was entered, friable soft tissue was appreciated (figure 4). Biopsies were taken, and cultures were sent to look for possible infectious etiologies.
Pathology revealed an "atypical lymphoid infiltrate consistent with idiopathic orbital inflammation, " a finding that was consistent with a pseudotumor ( figure 5 ). An additional steroid taper was prescribed, and the patient experienced further improvement in her vision. After a rheumatology evaluation, the patient was placed on a steroid-sparing regimen that included mycophenolate. Over time, her visual symptoms resolved, her vision returned to normal, and she had no limitations of her extraocular movements.
Discussion
Pseudotumor was first described in 1903 by Busse and Hochheim 3 and also by Gleason. 4 It was first called pseudotumor in 1905 by Birch-Hirschfeld. 5 It is important to keep in mind that this pathologic process has been referred to in other terms during the past century, including histiocytoma, plasma cell granuloma, lymphoproliferative disorder, xanthogranuloma, and mast cell granuloma.
Several theories have been proposed to explain the etiology of this condition. They include an autoimmune reaction involving both T and B lymphocytes, a chronic infectious process, and a spectrum of a lymphoproliferative disorder. 2 Patients may present with a myriad of complaints, including headaches, vision disturbances, swelling/asymmetry, and cranial nerve deficits. The specific symptoms depend on the site of anatomic involvement. In addition to a proper history and clinical examination, the workup should include endoscopy. The history taking should include specific questions related to neoplasia, inflammation, and autoimmunity. If an inflammatory or autoimmune etiology is suspected, appropriate laboratory evaluation is indicated.
Radiologic studies are an integral part of the diagnostic evaluation. CT and MRI provide complementary information, and both may be necessary to fully define the extent of the disease process. 2, 6 Findings typically seen on CT include bony erosion related to the presence of a mass-like lesion. On MRI, the lesions markedly enhance with gadolinium as a reflection of their inflammatory nature.
Pseudotumors have an isointense signal on T1weighted imaging and a hypointense signal on T2 weighting; this differentiates pseudotumor from other petrous apex lesions such as cholesterol granuloma and cholesteatoma, which are the two most common. Other possibilities may include infectious etiologies, mucoceles, chordomas, glomus tumors, chondrosarcomas, meningiomas, schwannomas, and metastatic lesions.
The lesion in our patient involved the petrous apex and cavernous sinus. Very few cases of idiopathic pseudotumor involving the petrous apex have been previously described. Moreover, our report is the first to document a transnasal endoscopic approach for biopsy of a petrous apex pseudotumor.
The anatomy of the petrous apex is complex, but an adequate appreciation of it is important to understanding the clinical manifestations of lesions that involve this area. The petrous apex is a pyramid-shaped area of the medial temporal bone. The apex is more anteromedial, and its base is posterolateral. It is bounded by the middle cranial fossa anterosuperiorly and the posterior cranial fossa posterosuperiorly. The clivus and cavernous sinus form the anteromedial border, and the otic capsule is found posterolaterally. The cavernous sinus is bordered by the sphenoid bone, sella turcica, and temporal bone laterally, and it carries the internal carotid artery and cranial nerves III, IV, V1, V2, and VI.
Our patient's symptoms were related to cranial nerve involvement in the cavernous sinus, but most of the lesion was focused on the petrous apex. After careful consideration, we decided to obtain a biopsy from the petrous apex.
Although imaging findings can be suggestive of a diagnosis of pseudotumor, they are typically not pathognomonic. 2, 6 For this reason, a tissue biopsy is often required to make the diagnosis. There is some controversy regarding the need for a tissue diagnosis, as some authors feel that a biopsy or excision can confer significant morbidity and risk and may aggravate the inflammatory condition even further. 7, 8 Recent advances in endoscopic skull base surgery have allowed for access to many parts of the skull base while causing less morbidity than open surgical techniques. The availability of these techniques may make it easier to decide to proceed with a biopsy in patients with a variety of skull base lesions, including idiopathic pseudotumor.
Access to the petrous apex has typically been obtained via an open craniotomy or transmastoid approach. The transmastoid approach preserves hearing, but it provides limited access and carries the risk of facial nerve injury. The House middle cranial fossa approach provides more exposure of larger lesions and preserves hearing, but it carries the typical risks of craniotomy, including brain retraction injury.
Others have described a transcanal infracochlear approach; this technique is useful for draining cystic lesions of the apex, but it offers very limited exposure. 9 Fisch infratemporal fossa approaches have been reported, as well, for even more medial access, but these techniques require a large incision and extensive dissection. In 1977, an open transethmoid-transsphenoid approach was described by Montgomery; this approach involves an incision at the medial canthus and the placement of a silicone stent to drain cystic lesions into the nose. 10 Each of these open approaches to the petrous apex is limited by its anatomic restrictions, including those imposed by the position of the otic capsule, facial nerve, brain, and orbital contents.
In our patient, an endoscopic approach allowed for excellent visualization and access for biopsy with a minimal postoperative hospital stay. The transnasal endoscopic approach to the petrous apex has been described previously. 11, 12 The approach involved the creation of a wide sphenoidotomy. Bone was then removed posterior and lateral to the paraclival portion of the carotid artery in order to access the petrous apex. The advantages of this approach include an absence of external incisions/ scarring, excellent visualization, and a shorter hospital stay. Disadvantages include the risks of skull base injury, cerebrospinal fluid leak, and carotid artery injury. Overall, the use of an endoscopic approach may provide access to petrous apex lesions with less morbidity than the traditional surgical approaches.
Biopsy results may show nonspecific inflammatory changes, including neutrophils, macrophages, plasma cells, and varying degrees of fibrosis, depending on the chronicity of the condition. There are no pathognomonic histologic findings for pseudotumor. It is important to consider the clinical and histologic findings together in order to make an accurate diagnosis. It is also important to rule out neoplastic processes by flow cytometry and immunohistochemistry.
High-dose steroids have been the mainstay of treatment for pseudotumor, and some authors consider steroid treatment a diagnostic test for this condition. Pseudotumor may improve symptomatically and radiologically as soon as 1 to 3 days after the initiation of steroid treatment. 2 An often-cited study of steroid efficacy by Mombaerts et al found that 78% of patients initially responded to therapy, but the recurrence rate was greater than 50%. 13 In a 2007 study of orbital pseudotumor, Chirapapaisan et al found clinical improvement with systemic steroids in 85% of patients and a recurrence rate of approximately 20%. 14 Other studies have documented higher rates of recurrence.
The effects of long-term high-dose steroid treatment are significant, and steroid-sparing agents have been used. For those patients who are unable to tolerate steroids or who have steroid-resistant disease, treatment options include radiation therapy, chemotherapy and, in some cases, surgical excision. Chiu and Rubin reported that low-dose radiotherapy is efficacious in 50 to 75% of patients. 15 Other possible pharmacologic options include cyclophosphamide, cyclosporine, azathioprine, and other nonsteroidal immunosuppressants, such as the mycophenolate, which was prescribed for our patient.
In conclusion, pseudotumor of the orbital and extraorbital areas, including the petrous apex of the temporal bone, is a poorly understood pathologic process for which continued research is needed. It is important that clinicians keep pseudotumor in the differential diagnosis of orbital and skull base lesions. Biopsy is essential to establish a diagnosis and to initiate appropriate management of what is a diagnosis of exclusion. Today's advances in endoscopic approaches to the skull base may contribute to improved diagnostic precision while minimizing the risks and morbidity of the procedure.
